How well is Helicobacter pylori treated in usual practice?

Kumaresan Yogeswaran, Grant Chen, Lawrence Cohen, Mary Anne Cooper, Elaine Yong, Eugene Hsieh, Corwyn Rowsell, Fred Saibil, Jill Tinmouth

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Helicobacter pylori is a WHO class I carcinogen also associated with nonmalignant gastrointestinal diseases. Effective treatment exists, and all persons infected with H pylori should receive treatment. However, data regarding the rates of treatment prescription in clinical practice are lacking. OBJECTIVE: To determine the rates of H pylori treatment in usual practice. METHODS: Patients with histological evidence of H pylori infection between January 1, 2007, and December 31, 2007, at Sunnybrook Health Sciences Centre (Toronto, Ontario) were identified. Charts were reviewed to determine the rates of H pylori treatment and confirmation of eradication, when indicated. Questionnaires were subsequently sent to endoscopists of patients identified as not having received treatment to determine the reasons for lack of treatment. RESULTS: A total of 102 patients were H pylori positive and were appropriate candidates for treatment, of whom 58 (57%) were male and 78 (76%) were outpatients, with 92 (90%) receiving eradication therapy. When indicated, 15 of 22 (68%) patients received confirmation of eradication, 13 of 18 (72%) patients underwent repeat endoscopy and 86% received complete therapy. Outpatients were more likely to receive eradication therapy (OR 10.3 [95% CI 2.6 to 40.4]; P=0.001) and complete therapy (OR 13.2 [95% CI 3.8 to 45.7]; P=0.0001) compared with inpatients. Having a follow-up appointment resulted in higher treatment rates (OR 12.0 [95% CI 3.0 to 47.5]; P=0.001). CONCLUSION: During the time period studied, adequate rates of H pylori treatment were achieved in outpatients and patients who had formal follow-up at Sunnybrook Health Sciences Centre. However, some aspects of care remain suboptimal including treatment of inpatients and care following treatment. Additional studies are required to identify strategies to improve the care of patients infected with H pylori.

Original languageEnglish (US)
Pages (from-to)543-546
Number of pages4
JournalCanadian Journal of Gastroenterology
Volume25
Issue number10
StatePublished - Oct 2011
Externally publishedYes

Fingerprint

Helicobacter pylori
Pylorus
Therapeutics
Outpatients
Inpatients
Gastrointestinal Diseases
Health
Ontario
Carcinogens
Endoscopy
Prescriptions
Patient Care
Appointments and Schedules

Keywords

  • Endoscopy
  • Follow-up
  • Helicobacter pylori
  • Inpatients
  • Outpatients
  • Treatment

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Yogeswaran, K., Chen, G., Cohen, L., Cooper, M. A., Yong, E., Hsieh, E., ... Tinmouth, J. (2011). How well is Helicobacter pylori treated in usual practice? Canadian Journal of Gastroenterology, 25(10), 543-546.

How well is Helicobacter pylori treated in usual practice? / Yogeswaran, Kumaresan; Chen, Grant; Cohen, Lawrence; Cooper, Mary Anne; Yong, Elaine; Hsieh, Eugene; Rowsell, Corwyn; Saibil, Fred; Tinmouth, Jill.

In: Canadian Journal of Gastroenterology, Vol. 25, No. 10, 10.2011, p. 543-546.

Research output: Contribution to journalArticle

Yogeswaran, K, Chen, G, Cohen, L, Cooper, MA, Yong, E, Hsieh, E, Rowsell, C, Saibil, F & Tinmouth, J 2011, 'How well is Helicobacter pylori treated in usual practice?', Canadian Journal of Gastroenterology, vol. 25, no. 10, pp. 543-546.
Yogeswaran K, Chen G, Cohen L, Cooper MA, Yong E, Hsieh E et al. How well is Helicobacter pylori treated in usual practice? Canadian Journal of Gastroenterology. 2011 Oct;25(10):543-546.
Yogeswaran, Kumaresan ; Chen, Grant ; Cohen, Lawrence ; Cooper, Mary Anne ; Yong, Elaine ; Hsieh, Eugene ; Rowsell, Corwyn ; Saibil, Fred ; Tinmouth, Jill. / How well is Helicobacter pylori treated in usual practice?. In: Canadian Journal of Gastroenterology. 2011 ; Vol. 25, No. 10. pp. 543-546.
@article{958201c4f84d49da98897dd4439592f4,
title = "How well is Helicobacter pylori treated in usual practice?",
abstract = "BACKGROUND: Helicobacter pylori is a WHO class I carcinogen also associated with nonmalignant gastrointestinal diseases. Effective treatment exists, and all persons infected with H pylori should receive treatment. However, data regarding the rates of treatment prescription in clinical practice are lacking. OBJECTIVE: To determine the rates of H pylori treatment in usual practice. METHODS: Patients with histological evidence of H pylori infection between January 1, 2007, and December 31, 2007, at Sunnybrook Health Sciences Centre (Toronto, Ontario) were identified. Charts were reviewed to determine the rates of H pylori treatment and confirmation of eradication, when indicated. Questionnaires were subsequently sent to endoscopists of patients identified as not having received treatment to determine the reasons for lack of treatment. RESULTS: A total of 102 patients were H pylori positive and were appropriate candidates for treatment, of whom 58 (57{\%}) were male and 78 (76{\%}) were outpatients, with 92 (90{\%}) receiving eradication therapy. When indicated, 15 of 22 (68{\%}) patients received confirmation of eradication, 13 of 18 (72{\%}) patients underwent repeat endoscopy and 86{\%} received complete therapy. Outpatients were more likely to receive eradication therapy (OR 10.3 [95{\%} CI 2.6 to 40.4]; P=0.001) and complete therapy (OR 13.2 [95{\%} CI 3.8 to 45.7]; P=0.0001) compared with inpatients. Having a follow-up appointment resulted in higher treatment rates (OR 12.0 [95{\%} CI 3.0 to 47.5]; P=0.001). CONCLUSION: During the time period studied, adequate rates of H pylori treatment were achieved in outpatients and patients who had formal follow-up at Sunnybrook Health Sciences Centre. However, some aspects of care remain suboptimal including treatment of inpatients and care following treatment. Additional studies are required to identify strategies to improve the care of patients infected with H pylori.",
keywords = "Endoscopy, Follow-up, Helicobacter pylori, Inpatients, Outpatients, Treatment",
author = "Kumaresan Yogeswaran and Grant Chen and Lawrence Cohen and Cooper, {Mary Anne} and Elaine Yong and Eugene Hsieh and Corwyn Rowsell and Fred Saibil and Jill Tinmouth",
year = "2011",
month = "10",
language = "English (US)",
volume = "25",
pages = "543--546",
journal = "Canadian Journal of Gastroenterology and Hepatology",
issn = "2291-2789",
publisher = "Pulsus Group Inc.",
number = "10",

}

TY - JOUR

T1 - How well is Helicobacter pylori treated in usual practice?

AU - Yogeswaran, Kumaresan

AU - Chen, Grant

AU - Cohen, Lawrence

AU - Cooper, Mary Anne

AU - Yong, Elaine

AU - Hsieh, Eugene

AU - Rowsell, Corwyn

AU - Saibil, Fred

AU - Tinmouth, Jill

PY - 2011/10

Y1 - 2011/10

N2 - BACKGROUND: Helicobacter pylori is a WHO class I carcinogen also associated with nonmalignant gastrointestinal diseases. Effective treatment exists, and all persons infected with H pylori should receive treatment. However, data regarding the rates of treatment prescription in clinical practice are lacking. OBJECTIVE: To determine the rates of H pylori treatment in usual practice. METHODS: Patients with histological evidence of H pylori infection between January 1, 2007, and December 31, 2007, at Sunnybrook Health Sciences Centre (Toronto, Ontario) were identified. Charts were reviewed to determine the rates of H pylori treatment and confirmation of eradication, when indicated. Questionnaires were subsequently sent to endoscopists of patients identified as not having received treatment to determine the reasons for lack of treatment. RESULTS: A total of 102 patients were H pylori positive and were appropriate candidates for treatment, of whom 58 (57%) were male and 78 (76%) were outpatients, with 92 (90%) receiving eradication therapy. When indicated, 15 of 22 (68%) patients received confirmation of eradication, 13 of 18 (72%) patients underwent repeat endoscopy and 86% received complete therapy. Outpatients were more likely to receive eradication therapy (OR 10.3 [95% CI 2.6 to 40.4]; P=0.001) and complete therapy (OR 13.2 [95% CI 3.8 to 45.7]; P=0.0001) compared with inpatients. Having a follow-up appointment resulted in higher treatment rates (OR 12.0 [95% CI 3.0 to 47.5]; P=0.001). CONCLUSION: During the time period studied, adequate rates of H pylori treatment were achieved in outpatients and patients who had formal follow-up at Sunnybrook Health Sciences Centre. However, some aspects of care remain suboptimal including treatment of inpatients and care following treatment. Additional studies are required to identify strategies to improve the care of patients infected with H pylori.

AB - BACKGROUND: Helicobacter pylori is a WHO class I carcinogen also associated with nonmalignant gastrointestinal diseases. Effective treatment exists, and all persons infected with H pylori should receive treatment. However, data regarding the rates of treatment prescription in clinical practice are lacking. OBJECTIVE: To determine the rates of H pylori treatment in usual practice. METHODS: Patients with histological evidence of H pylori infection between January 1, 2007, and December 31, 2007, at Sunnybrook Health Sciences Centre (Toronto, Ontario) were identified. Charts were reviewed to determine the rates of H pylori treatment and confirmation of eradication, when indicated. Questionnaires were subsequently sent to endoscopists of patients identified as not having received treatment to determine the reasons for lack of treatment. RESULTS: A total of 102 patients were H pylori positive and were appropriate candidates for treatment, of whom 58 (57%) were male and 78 (76%) were outpatients, with 92 (90%) receiving eradication therapy. When indicated, 15 of 22 (68%) patients received confirmation of eradication, 13 of 18 (72%) patients underwent repeat endoscopy and 86% received complete therapy. Outpatients were more likely to receive eradication therapy (OR 10.3 [95% CI 2.6 to 40.4]; P=0.001) and complete therapy (OR 13.2 [95% CI 3.8 to 45.7]; P=0.0001) compared with inpatients. Having a follow-up appointment resulted in higher treatment rates (OR 12.0 [95% CI 3.0 to 47.5]; P=0.001). CONCLUSION: During the time period studied, adequate rates of H pylori treatment were achieved in outpatients and patients who had formal follow-up at Sunnybrook Health Sciences Centre. However, some aspects of care remain suboptimal including treatment of inpatients and care following treatment. Additional studies are required to identify strategies to improve the care of patients infected with H pylori.

KW - Endoscopy

KW - Follow-up

KW - Helicobacter pylori

KW - Inpatients

KW - Outpatients

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=80054753981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054753981&partnerID=8YFLogxK

M3 - Article

C2 - 22059158

AN - SCOPUS:80054753981

VL - 25

SP - 543

EP - 546

JO - Canadian Journal of Gastroenterology and Hepatology

JF - Canadian Journal of Gastroenterology and Hepatology

SN - 2291-2789

IS - 10

ER -